Found: 95
Select item for more details and to access through your institution.
A common pattern of somatic mutations in t‐MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E400, doi. 10.1002/ajh.26697
- By:
- Publication type:
- Article
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1746, doi. 10.3390/jpm12101746
- By:
- Publication type:
- Article
Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 1, p. 3, doi. 10.3390/jpm12010003
- By:
- Publication type:
- Article
The Role of Artificial Intelligence in Managing Multimorbidity and Cancer.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 4, p. 314, doi. 10.3390/jpm11040314
- By:
- Publication type:
- Article
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.979519
- By:
- Publication type:
- Article
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.880008
- By:
- Publication type:
- Article
How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.844801
- By:
- Publication type:
- Article
Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2845, doi. 10.3390/cancers16162845
- By:
- Publication type:
- Article
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1769, doi. 10.3390/cancers16091769
- By:
- Publication type:
- Article
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1400, doi. 10.3390/cancers15051400
- By:
- Publication type:
- Article
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5955, doi. 10.3390/cancers14235955
- By:
- Publication type:
- Article
Role of Homologous Recombination Repair (HRR) Genes in Uterine Leiomyosarcomas: A Retrospective Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1934, doi. 10.3390/cancers14081934
- By:
- Publication type:
- Article
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1849, doi. 10.3390/cancers14071849
- By:
- Publication type:
- Article
PARP Inhibitors Resistance: Mechanisms and Perspectives.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1420, doi. 10.3390/cancers14061420
- By:
- Publication type:
- Article
Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1285, doi. 10.3390/cancers14051285
- By:
- Publication type:
- Article
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 889, doi. 10.3390/cancers14040889
- By:
- Publication type:
- Article
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4438, doi. 10.3390/cancers13174438
- By:
- Publication type:
- Article
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2089, doi. 10.3390/cancers13092089
- By:
- Publication type:
- Article
Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1298, doi. 10.3390/cancers13061298
- By:
- Publication type:
- Article
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1584, doi. 10.3390/cancers11101584
- By:
- Publication type:
- Article
The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Potential impact of introducing a nonavalent HPV vaccination.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar Junction.
- Published in:
- Reproductive Sciences, 2019, v. 26, n. 1, p. 44, doi. 10.1177/1933719118756747
- By:
- Publication type:
- Article
Is Postoperative Computed Tomography Evaluation a Prognostic Indicator in Patients with Optimally Debulked Advanced Ovarian Cancer?
- Published in:
- Oncology, 2014, v. 87, n. 5, p. 293, doi. 10.1159/000365357
- By:
- Publication type:
- Article
High-Risk Borderline Ovarian Tumors: Analysis of Clinicopathological Features and Prognostic Impact of Different Follow-Up Strategies.
- Published in:
- Oncology, 2014, v. 87, n. 3, p. 183, doi. 10.1159/000360990
- By:
- Publication type:
- Article
Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study.
- Published in:
- Oncology, 2011, v. 81, n. 2, p. 104, doi. 10.1159/000331677
- By:
- Publication type:
- Article
Phase I Study of Gemcitabine and Liposomal Doxorubicin in Relapsed Ovarian Cancer.
- Published in:
- Oncology, 2002, v. 62, n. 2, p. 110, doi. 10.1159/000048255
- By:
- Publication type:
- Article
Topotecan and Gemcitabine in Platinum/Paclitaxel-Resistant Ovarian Cancer.
- Published in:
- Oncology, 2001, v. 60, n. 1, p. 19, doi. 10.1159/000055291
- By:
- Publication type:
- Article
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. 25, doi. 10.1093/oncolo/oyad201
- By:
- Publication type:
- Article
Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. 1058, doi. 10.1093/oncolo/oyac188
- By:
- Publication type:
- Article
Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. e536, doi. 10.1634/theoncologist.2018-0338
- By:
- Publication type:
- Article
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 9, p. 845, doi. 10.3390/biology10090845
- By:
- Publication type:
- Article
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 725, p. 1, doi. 10.1126/scitranslmed.adi2556
- By:
- Publication type:
- Article
High-Grade Serous Tumor Arising from Fallopian Tube in a BRCA Mutation Carrier after Prophylactic Oophorectomy.
- Published in:
- Case Reports in Oncology, 2013, v. 6, n. 1, p. 21, doi. 10.1159/000346339
- By:
- Publication type:
- Article
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study.
- Published in:
- Journal of Ovarian Research, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13048-022-00970-w
- By:
- Publication type:
- Article
Peritoneal cytology as prognostic factor in cervical cancer.
- Published in:
- Diagnostic Cytopathology, 2015, v. 43, n. 9, p. 705, doi. 10.1002/dc.23296
- By:
- Publication type:
- Article
Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221126149
- By:
- Publication type:
- Article
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.
- Published in:
- British Journal of Cancer, 2018, v. 119, n. 5, p. 565, doi. 10.1038/s41416-018-0190-y
- By:
- Publication type:
- Article
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 4, p. 1385, doi. 10.1007/s12325-024-02791-3
- By:
- Publication type:
- Article
LASER treatment for women with high‐grade vaginal intraepithelial neoplasia: A propensity‐matched analysis on the efficacy of ablative versus excisional procedures.
- Published in:
- Lasers in Surgery & Medicine, 2018, v. 50, n. 9, p. 933, doi. 10.1002/lsm.22941
- By:
- Publication type:
- Article
LASER treatment for women with high-grade vaginal intraepithelial neoplasia: A propensity-matched analysis on the efficacy of ablative versus excisional procedures.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 6, p. 935, doi. 10.1007/s00428-023-03552-3
- By:
- Publication type:
- Article
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2021, v. 478, n. 2, p. 153, doi. 10.1007/s00428-020-03007-z
- By:
- Publication type:
- Article
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 11, p. 3396, doi. 10.1245/s10434-017-6030-0
- By:
- Publication type:
- Article
When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, p. 944, doi. 10.1245/s10434-015-4799-2
- By:
- Publication type:
- Article
Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 13, p. 4204, doi. 10.1245/s10434-015-4504-5
- By:
- Publication type:
- Article